Literature DB >> 6179660

Plasma catecholamines and cardiovascular responses during converting enzyme inhibition in normotensive and hypertensive man.

A P Niarchos, T G Pickering, A Morganti, J H Laragh.   

Abstract

The hemodynamic and plasma catecholamine responses to isometric exercise and head up tilt were investigated in normotensive and hypertensive subjects during normal and low sodium intake and before and during the administration of the converting enzyme inhibitors teprotide or captopril. Although teprotide and captopril decreased significantly the mean arterial pressure during both sodium intakes the normal pattern of hemodynamic response to hand grip and head up tilt was preserved. Moreover changes of plasma catecholamines during hand grip and head up tilt were not affected either by teprotide or captopril. When following the administration of teprotide or captopril fainting occurred either in the seated position or during head up tilt it was associated not only with a decrease in arterial pressure but also with a concurrent reduction in cardiac output and/or hypovolemia. It is concluded that converting enzyme inhibition does not impair significantly the cardiovascular responses which are mediated via the sympathetic nervous system either in normotensive or in hypertensive subjects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179660     DOI: 10.3109/10641968209061612

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  9 in total

1.  The effect of angiotensin II on endogenous noradrenaline release in man.

Authors:  P H Seidelin; W J Coutie; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

2.  Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.

Authors:  K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

Review 3.  Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies.

Authors:  Samuel J Mann
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

4.  The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.

Authors:  A A Ajayi; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

5.  Effects of angiotensin converting enzyme inhibitor, perindopril, on autonomic reflexes.

Authors:  A A Ajayi; K R Lees; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.

Authors:  D H Roberts; Y Tsao; S F Grimmer; P A Winstanley; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

7.  The effect of captopril on the reflex control heart rate: possible mechanisms.

Authors:  A A Ajayi; B C Campbell; P A Meredith; A W Kelman; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

Review 8.  The clinical spectrum of labile hypertension: a management dilemma.

Authors:  Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-09       Impact factor: 3.738

Review 9.  Amlodipine and valsartan as components of a rational and effective fixed-dose combination.

Authors:  Bernard Waeber; Luis M Ruilope
Journal:  Vasc Health Risk Manag       Date:  2009-04-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.